BTLA and diffuse large B-cell lymphoma: BTLA expression has also been reported in diffuse large B cell lymphoma (DLBCL) and follicular lymphoma, primarily on intratumoral T cells and B cells, with emerging data indicating that BTLA may predict therapeutic resistance or unfavorable immune subtypes [54].